You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
RECOMBINANT ANTIBODIES AS INTRA VAGINAL SPERMICIDES
SBC: CONTRAVAC, INC. Topic: N/AWorld population is predicted to reach 10 billion people by the year 2050, increasing more than 75% over the current population. Development of new contraceptive options is necessary to provide accessible birth control to all individuals regardless of sociological, financial, or educational limitations. Current literature implicates marketed spermicidal formulations in cervical and vaginal irritat ...
SBIR Phase I 1997 Department of Health and Human Services -
PHARMACOLOGICAL INHIBITION OF INTRAOCULAR PROLIFERATION
SBC: Control Delivery Systems, Inc. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
RECHARGEABLE LI ION CELLS FOR VAS APPLICATION
SBC: COVALENT ASSOC., INC. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
OP-1 3D STRUCTURE USED IN DRUG DESIGN FOR BONE DISORDERS
SBC: CREATIVE BIOMOLECULES, INC. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
REAL TIME CARDIOPULMONARY CASE SIMULATION ON THE WEB
SBC: Critical Concepts, Inc. Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
RECOMBINANT MIS CANCER THERAPEUTIC PRODUCED IN PLANTS
SBC: CROPTECH CORPORATION Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
DEVELOPMENT OF A SCREEN FOR BACTERIAL RNASE P INHIBITORS
SBC: CUBIST PHARMACEUTICALS, INC. Topic: N/AThe need for novel antibiotics has never been greater. Infectious diseases are the third cause of death in the US, and their toll is increasing, with a 580/0 increase in mortality from 1980 to 1992. A large reason for this rise is the evolution and spread of antibiotic- resistant bacteria. We plan to combat this rise in antibiotic resistance by identifying inhibitors of novel bacterial targets to ...
SBIR Phase I 1997 Department of Health and Human Services -
DEVELOPMENT OF A NOVEL TARGET FOR ANTIMICROBIAL DRUG
SBC: CUBIST PHARMACEUTICALS, INC. Topic: N/ADESCRIPTION: Emergence of antibiotic-resistant microbial pathogens has created a medical crisis. Life-threatening bacterial pathogens, such as Staphylococcus aureus and Entercoccus faecalis, have developed widespread resistance to current antibiotics. Development of new antibiotics has been traditionally based on derivatizing known classes of compounds which target a limited number of cellular pro ...
SBIR Phase I 1997 Department of Health and Human Services -
CYTOKINE EFFECTS ON STEM CELLS USING A NOVEL BIOREACTOR
SBC: Cytomatrix, LLC Topic: N/AN/A
SBIR Phase I 1997 Department of Health and Human Services -
PATIENT REGISTRATION SYSTEM FOR RADIATION THERAPY
SBC: DCS CORP. Topic: N/AIn radiation oncology, it is important to precisely position patients undergoing radiation therapy repeatably during each session over the course of treatment. Current methods for doing this positioning are time consuming and do not meet the accuracy requirements of advanced 3-D radiation treatment planning. DCS Corporation has developed an innovative high-speed 3-D topographical surface mapping ...
SBIR Phase I 1997 Department of Health and Human Services
